Fatal Hepatocerebral Syndrome in Siblings Discordant for Exposure to Valproate
- 1 October 1990
- Vol. 31 (5) , 578-583
- https://doi.org/10.1111/j.1528-1157.1990.tb06109.x
Abstract
Occurrence of a progressive encephalopathy with seizures in siblings was associated with hepatic pathology. One of these patients was exposed to valproate (VPA) and developed hepatic necrosis, confirmed at autopsy. The other had not been exposed to VPA, and her hepatic lesions at autopsy were less severe. The liver pathology in both was within the range described in previous cases of liver disease attributed to VPA. These facts and the otherwise similar course of their disease suggests that in these patients, and probably in other cases of fatal liver failure attributed to VPA, the drug actually either had no effect or acted only to increase the severity of the preexisting hepatic component of the hepatocerebral disorder.Keywords
This publication has 16 references indexed in Scilit:
- Transmission of Alpers' disease (chronic progressive encephalopathy) produces experimental Creutzfeldt‐Jakob disease in hamstersNeurology, 1989
- Valproic acid hepatic fatalitiesNeurology, 1987
- Cytochrome P-450—Catalyzed Formation of Δ4-VPA, a Toxic Metabolite of Valproic AcidScience, 1987
- PROGRESSIVE NEURONAL DEGENERATION OF CHILDHOOD WITH LIVER DISEASEBrain, 1986
- An Update on Sodium ValproatePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1985
- Valproic acid versus ethosuximide in the treatment of absence seizuresNeurology, 1982
- A direct hepatotoxic effect of valproic acidJAMA, 1979
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979
- Infantile Diffuse Cerebral Degeneration With Hepatic CirrhosisArchives of Neurology, 1976
- DIFFUSE PROGRESSIVE DEGENERATION OF THE GRAY MATTER OF THE CEREBRUMArchives of Neurology & Psychiatry, 1931